|
|
Exchange: |
N/A |
Security
Type: |
N/A |
Shares
Out: |
208,280,000 |
Market
Cap: |
1.72(B) |
Last
Volume: |
0 |
Avg
Vol: |
0 |
52
Week Range: |
$5.09 - $15.86 |
|
Level
I Sector: |
N/A |
Level
II Sector: |
N/A |
Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : - |
Guru Rank Value : - |
Guru Occurances : - |
|
|
|
|
|
|
|
Company Profile Recursion Pharmaceuticals is a clinical-stage biotechnology company that combines automation, artificial intelligence, machine learning, in vivo validation capabilities and a cross-functional team to discover medicines. Co.'s potential medicines include: REC-994 for the treatment of cerebral cavernous malformation; REC-2282 for the treatment of neurofibromatosis type 2; REC-4881 for the treatment of familial adenomatous polyposis; REC-3599 for the treatment of GM2 gangliosidosis; REC-3964 for the treatment of C. difficile colitis; REC-64917 for neural or systemic inflammation; and multiple simultaneous programs in fibrosis developing with Bayer AG.
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
0 |
1,693,990 |
Total Buy Value |
$0 |
$0 |
$0 |
$12,897,789 |
Total People Bought |
0 |
0 |
0 |
1 |
Total Buy Transactions |
0 |
0 |
0 |
27 |
Total Shares Sold |
571,393 |
1,097,598 |
2,167,677 |
3,032,147 |
Total Sell Value |
$5,405,839 |
$10,600,247 |
$21,388,578 |
$28,929,957 |
Total People Sold |
4 |
7 |
8 |
8 |
Total Sell Transactions |
23 |
46 |
95 |
150 |
End Date |
2024-03-03 |
2023-12-01 |
2023-06-02 |
2022-06-02 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Gibson Christopher |
Chief Executive Officer |
|
2022-08-17 |
4/A |
A |
$0.00 |
$0 |
D/D |
3,000 |
585,805 |
|
- |
|
Larson Tina Marriott |
President and COO |
|
2022-08-16 |
4 |
AS |
$12.60 |
$201,637 |
D/D |
(16,000) |
295,107 |
|
-42% |
|
Larson Tina Marriott |
President and COO |
|
2022-08-16 |
4 |
OE |
$1.06 |
$16,960 |
D/D |
16,000 |
221,107 |
|
- |
|
Virani Shafique |
Chief Business Officer |
|
2022-08-16 |
4 |
AS |
$12.61 |
$378,444 |
D/D |
(30,000) |
98,773 |
|
-42% |
|
Virani Shafique |
Chief Business Officer |
|
2022-08-16 |
4 |
OE |
$2.22 |
$55,500 |
D/D |
25,000 |
128,773 |
|
- |
|
Gibson Christopher |
Chief Executive Officer |
|
2022-08-15 |
4 |
D |
$12.96 |
$74,533 |
D/D |
(5,751) |
536,078 |
|
- |
|
Larson Tina Marriott |
President and COO |
|
2022-08-15 |
4 |
D |
$12.96 |
$18,831 |
D/D |
(1,453) |
205,107 |
|
- |
|
Virani Shafique |
Chief Business Officer |
|
2022-08-15 |
4 |
D |
$12.96 |
$7,944 |
D/D |
(613) |
103,773 |
|
- |
|
Secora Michael |
Chief Financial Officer |
|
2022-08-15 |
4 |
D |
$12.96 |
$13,802 |
D/D |
(1,065) |
587,637 |
|
- |
|
Gibson Christopher |
Chief Executive Officer |
|
2022-08-04 |
4 |
AS |
$9.44 |
$23,617 |
I/I |
(2,500) |
0 |
|
-12% |
|
Gibson Christopher |
Chief Executive Officer |
|
2022-08-04 |
4 |
A |
$0.00 |
$0 |
I/I |
2,500 |
1,000 |
|
- |
|
Gibson Christopher |
Chief Executive Officer |
|
2022-08-04 |
4 |
AS |
$9.45 |
$349,441 |
D/D |
(36,825) |
541,829 |
|
-12% |
|
Gibson Christopher |
Chief Executive Officer |
|
2022-08-04 |
4 |
A |
$0.00 |
$0 |
D/D |
18,500 |
560,329 |
|
- |
|
Gibson Christopher |
Chief Executive Officer |
|
2022-08-04 |
4 |
OE |
$2.48 |
$77,500 |
D/D |
31,250 |
560,154 |
|
- |
|
Gibson Christopher |
Chief Executive Officer |
|
2022-07-19 |
4/A |
GD |
$0.00 |
$0 |
D/D |
3,000 |
582,805 |
|
- |
|
Gibson Christopher |
Chief Executive Officer |
|
2022-07-19 |
4/A |
A |
$0.00 |
$0 |
D/D |
3,000 |
585,805 |
|
- |
|
Dar Zavain |
Director |
|
2022-07-08 |
4 |
A |
$0.00 |
$0 |
D/D |
2,420 |
20,565 |
|
- |
|
Gibson Christopher |
Chief Executive Officer |
|
2022-07-07 |
4 |
AS |
$9.06 |
$22,669 |
I/I |
(2,500) |
0 |
|
32% |
|
Gibson Christopher |
Chief Executive Officer |
|
2022-07-07 |
4 |
A |
$0.00 |
$0 |
I/I |
2,500 |
1,000 |
|
- |
|
Gibson Christopher |
Chief Executive Officer |
|
2022-07-07 |
4 |
AS |
$9.04 |
$335,978 |
D/D |
(37,114) |
528,904 |
|
32% |
|
Gibson Christopher |
Chief Executive Officer |
|
2022-07-07 |
4 |
A |
$0.00 |
$0 |
D/D |
18,500 |
547,404 |
|
- |
|
Gibson Christopher |
Chief Executive Officer |
|
2022-07-07 |
4 |
OE |
$2.48 |
$77,500 |
D/D |
31,250 |
547,518 |
|
- |
|
Chavez R Martin Phd |
Director |
|
2022-07-01 |
4 |
A |
$0.00 |
$0 |
D/D |
2,224 |
31,476 |
|
- |
|
Borgeson Blake |
Director |
|
2022-07-01 |
4 |
A |
$0.00 |
$0 |
D/D |
1,186 |
7,671,777 |
|
- |
|
Li Dean Y |
Director |
|
2022-07-01 |
4 |
A |
$0.00 |
$0 |
D/D |
1,409 |
619,020 |
|
- |
|
618 Records found
|
|
Page 16 of 25 |
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Acquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|